Trials / Completed
CompletedNCT02349815
JAYDESS Drug Utilization Study in Sweden
Pharmacoepidemiological Study (Drug Utilization Study) of JAYDESS Use in Routine Clinical Practice in Sweden
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
* To describe characteristics (demographic, clinical, social) of first time users of Jaydess * To estimate the duration of use of Jaydess * To study switching patterns, e.g. what are the hormonal contraceptive methods used before and what are the methods after discontinuing Jaydess * To study off-label use of Jaydess
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levonorgestrel (Jaydess, Skyla, BAY86-5028) | Women use Levonorgestrel (Jaydess, BAY86-5028) . |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2022-04-01
- Completion
- 2022-04-01
- First posted
- 2015-01-29
- Last updated
- 2023-01-31
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02349815. Inclusion in this directory is not an endorsement.